MabCure
$0
7
+$0+0% Thursday 20:00
Statistics
Day High
0
Day Low
0
52W High
0
52W Low
0
Volume
1,000
Avg. Volume
251
Mkt Cap
78,109
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
31DecConfirmed
Expected EPS
N/A
Actual EPS
-0.1765
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MBCI. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Biotechnology
Health Technology
MabCure Inc., a development stage company, engages in developing and commercializing its proprietary antibody technology for the early detection of cancer, and for the creation of specific therapeutics against cancer. It owns a proprietary technology for the generation of monoclonal antibodies against desired antigens, such as cancer markers. The company was formerly known as Smartec Holdings, Inc. and changed its name to MabCure Inc. in January 2008 to reflect its new business plan. MabCure Inc. was founded in 2006 and is based in White Plains, New York.
Show more...
CEO
Employees
3
Country
US
ISIN
US5540941029